Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 31, Issue 7, 2004, Pages 964-968

  Schirrmeister, Holger ^a   Arslandemir, Coskun ^b   Glatting, Gerhard ^b   Mayer Steinacker, Regine ^b   Bommer, Martin ^b   Dreinhöfer, Karsten ^b   Buck, Andreas ^b   Hetzel, Martin ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Asymptomatic patients; Bone metastases; Bone scan; Nonsmall cell lung cancer; Skeletal scintigraphy

Indexed keywords

FLUORIDE SODIUM; FLUORINE 18; MEDRONAT AMERSCAN; MEDRONATE TECHNETIUM TC 99M; SODIUM FLUORIDE F 18; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASYMPTOMATIC PATIENT; BONE METASTASIS; BONE PAIN; BONE SCINTISCANNING; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DISEASE COURSE; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 3142702739     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1492-2     Document Type: Article

References (24)

1. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111:1710-1717.
2. Spiro SG, Porter JC. Lung cancer-where are we today? Current advances in staging and nonsurgical treatment. Am J Respir Crit Care Med 2002; 166:1166-1196.
3. Michel F, Soler M, Imhof E, Perruchoud AP. Initial staging of non-small cell lung cancer: value of routine radioisotope bone scanning. Thorax 1991; 46:469-473.
4. Yano T, Yokoyama H, Inoue T, et al. The first site of recurrence after complete resection in non-small-cell carcinoma of the lung. Comparison between pN0 disease and pN2 disease. J Thorac Cardiovasc Surg 1994; 108:680-683.
5. Osada H, Nakajima Y, Taira Y, Yokote K, Noguchi T. The role of mediastinal and multi-organ CT scans in staging presumable surgical candidates with non-small-cell lung cancer. Jpn J Surg 1987; 17:362-368.
6. Salvatierra A, Baamonde C, Llamas JM, Cruz F, Lopez-Pujol J. Extrathoracic staging of bronchogenic carcinoma. Chest 1990; 97:1052-1058.
7. Hooper RG, Beechler CR, Johnson MC. Radioisotope scanning in the initial staging of bronchogenic carcinoma. Am Rev Respir Dis 1978; 118:279-286.
8. Ramsdell JW, Peters RM, Taylor AT Jr., Alazraki NP, Tisi GM. Multiorgan scans for staging lung cancer. Correlation with clinical evaluation. J Thorac Cardiovasc Surg 1977; 73:53-59.
9. Turner P, Haggith JW. Preoperative radionuclide scanning in bronchogenic carcinoma. Br J Dis Chest 1981; 75:291-294.
10. Tornyos K, Garcia O, Karr B, LeBeaud R. A correlation study of bone scanning with clinical and laboratory findings in the staging of nonsmall-cell lung cancer. Clin Nucl Med 1991; 16:107-109.
11. Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003; 123:137S-146S.
12. Haubold-Reuter BG, Duewell S, Schilcher BR, Marincek B, von Schulthess GK. The value of bone scintigraphy, bone marrow scintigraphy and fast spin-echo magnetic resonance imaging in staging of patients with malignant solid tumors: a prospective study. Eur J Nucl Med 1993; 20:1063-1069.
13. Hochstenbag MM, Snoep G, Cobben NA, et al. Detection of bone marrow metastases in small cell lung cancer. Comparison of magnetic resonance imaging with standard methods. Eur J Cancer 1996; 32A:779-782.
14. 18F PET. J Nucl Med 1999; 40:1623-1629.
15. 18F-fluoride ion and positron emission tomography. J Clin Oncol 1999; 17:2381-2389.
16. Krasnow AZ, Hellman RS, Timins ME, Collier BD, Anderson T, Isitman AT. Diagnostic bone scanning in oncology. Semin Nucl Med 1997; 27:107-141.
17. Robertson JT. The rape of the spine. Surg Neurol 1993; 39:5-12.
18. Deyo RA, Tsui-Wu Y-J. Descriptive epidemiology of low-back pain and its related medical care in the United States. Spine 1987; 12:264-268.
19. Pretreatment evaluation of non-small-cell lung cancer. The American Thoracic Society and The European Respiratory Society. Am J Respir Crit Care Med 1997; 156:320-332.
20. Silvestri GA, Tanoue LT, Margolis ML, Barker J, Detterbeck F. The noninvasive staging of non-small cell lung cancer: the guidelines. Chest 2003; 123:147S-156S.
21. 99mTc-phosphate bone scan and skeletal radiograph in the diagnosis of bone metastases. Clin Radiol 1977; 28:107-117.
22. Frank JA, Ling A, Patronas NJ, et al. Detection of malignant bone tumors: MR imaging vs scintigraphy. Am J Roentgenol 1990; 155:1043-1048.
23. Even-Sapir E, Martin RH, Barnes DC, Pringle CR, Iles SE, Mitchell MJ. Role of SPECT in differentiating malignant from benign lesions in the lower thoracic and lumbar vertebrae. Radiology 1993; 187:193-198.
24. Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002; 346:92-98.